← Browse by Condition
Medical Condition
biochemically recurrent prostate carcinoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT06378866 Phase 2
Recruiting
Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial
Enrollment
532 pts
Location
United States
Sponsor
Mayo Clinic
NCT05054296 Phase 2
Recruiting
Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modification Program and Continuous Fitbit Monitoring
Enrollment
200 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center